Regulatory Information
A. MENARINI SINGAPORE PTE. LTD.
A. MENARINI SINGAPORE PTE. LTD.
Therapeutic
Prescription Only
Formulation Information
TABLET, SUGAR COATED
**Indications and dosage** Intestinal atony, atonic constipation: 1 dragée 60mg or 1 – 2 ampoules 1 mg i.m. as required, e.g. at intervals of four hours. Myasthenia gravis: 1 – 3 dragées 60 mg two to four times daily; more in severe cases. If required, single doses of 2 – 5 ampoules s.c. or i.m.
ORAL
Medical Information
The indication(s) is given in the **Dosage** section.
N07AA02
pyridostigmine
Manufacturer Information
A. MENARINI SINGAPORE PTE. LTD.
LABIANA PHARMACEUTICALS S.L.U
Active Ingredients
Documents
Package Inserts
2013MEN-504-1 Mestinon 60mg 150s Insert (HK,SG) 24May2013.pdf
Approved: July 8, 2013